This site uses cookies to store information on your computer. Learn more x

H1 Results 2018

DSM published its H1 Results 2018 on 1 August. The H1 highlights are:

  • DSM reports a very good H1 with strong performance across all businesses
  • Continued strong organic sales growth in underlying business estimated at 10%
  • Adjusted EBITDA growth of underlying business estimated at 7%, despite significant FX headwind
  • ROCE of underlying business estimated at 13.8%, up 160 bps
    Additional temporary vitamin price benefit estimated at €275m on Adjusted EBITDA
  • Total Adjusted EBITDA up 45% and Net profit up 103% to €633m
  • Cash from Operating Activities €503m up 53%
  • Interim dividend of €0.77, reflecting the proposed dividend increase of about 25% for 2018
  • Full year outlook reconfirmed

Share price and volume

Share price> € 0.0 0.0%

More share info >